Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Patricia Steinert PhD

Patricia Steinert PhD profile photo picture

Associate Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Bone Marrow Transplant

image of /images/ORCIDiD_icon16x16.png   https://orcid.org/0000-0003-2199-2734

Member of the Center for International Blood and Marrow Transplant Research (CIBMTR)


I am willing to collaborate on research projects.
I am willing to be a peer mentor.
I am willing to mentor a junior faculty member.

View Curriculum Vitae

Research Areas of Interest

  • Anemia, Sickle Cell
  • Databases, Factual
  • Hematopoietic Stem Cell Transplantation

    • Research Experience

  • Hematopoietic Stem Cell Transplantation

    • Methodologies and Techniques

  • Databases, Factual

    • Leadership Positions

  • Executive Scientific Director, CIBMTR

    • Publications (17)

  • Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research. (Auletta JJ, Kou J, Chen M, Bolon YT, Broglie L, Bupp C, Christianson D, Cusatis RN, Devine SM, Eapen M, Hamadani M, Hengen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Perez WS, Phelan R, Riches ML, Rizzo JD, Saber W, Spellman SR, Stefanski HE, Steinert P, Tuschl E, Yusuf R, Zhang MJ, Shaw BE) Transplant Cell Ther 2023 Jun;29(6):346.e1-346.e10 PMID: 36924931 PMCID: PMC10239334 SCOPUS ID: 2-s2.0-85153327578 03/17/2023       12 Citations
  • Association of demographic factors and medical school research productivity with dermatology residency tier placement: A national cohort study. (Zhu H, Huang A, Zhou K, Bhatnagar A, Sorensen R, Cordova K, Calderara GA, Dasari N, Kirby RP, Kim SJ) J Am Acad Dermatol 2023 Jul;89(1):186-188 PMID: 36924932 SCOPUS ID: 2-s2.0-85152672348 03/17/2023       1 Citation
  • Corrigendum to 'Current Use and Trends in Hematopoietic Cell Transplantation in the United States' [Transplantation and Cellular Therapy 26/8 (2020) e177-e182]. (D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM) Transplant Cell Ther 2022 Oct;28(10):715-716 PMID: 36202526 SCOPUS ID: 2-s2.0-85108559179 10/07/2022       1 Citation
  • Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182, (S1083879120302251), (10.1016/j.bbmt.2020.04.013)] (D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM) Transplantation and Cellular Therapy October 2022;28(10):715-716 SCOPUS ID: 2-s2.0-85108559179 10/01/2022       1 Citation
  • Trends in Allogeneic Hematopoietic Cell Transplantation Utilization and Estimated Unmet Need Among Medicare Beneficiaries with Acute Myelogenous Leukemia. (Mau LW, Preussler JM, Meyer CL, Senneka MK, Wallerstedt S, Steinert P, Khera N, Saber W) Transplant Cell Ther 2022 Dec;28(12):852-858 PMID: 36170959 PMCID: PMC10183994 SCOPUS ID: 2-s2.0-85143510594 09/29/2022       1 Citation
  • Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes. (Phelan R, Chen M, Bupp C, Bolon YT, Broglie L, Brunner-Grady J, Burns LJ, Chhabra S, Christianson D, Cusatis R, Devine SM, D'Souza A, Eapen M, Hamadani M, Hengen M, Lee SJ, Moskop A, Page KM, Pasquini M, Pérez WS, Riches M, Rizzo D, Saber W, Spellman SR, Stefanski HE, Steinert P, Weisdorf D, Horowitz M, Auletta JJ, Shaw BE, Arora M) Transplant Cell Ther 2022 Jul;28(7):409.e1-409.e10 PMID: 35447374 PMCID: PMC9840526 SCOPUS ID: 2-s2.0-85130441260 04/22/2022       22 Citations
  • Long-term Survival after Hematopoietic Cell Transplant for Sickle Cell Disease Compared to the United States Population. (St Martin A, Hebert KM, Serret-Larmande A, Jouhet V, Hughes E, Stedman J, DeSain T, Pillion D, Lyons JC, Steinert P, Avillach P, Eapen M) Transplant Cell Ther 2022 Jun;28(6):325.e1-325.e7 PMID: 35302009 PMCID: PMC9198002 SCOPUS ID: 2-s2.0-85128216222 03/19/2022       6 Citations
  • A Prospective Cohort Study Comparing Long-Term Outcomes with and without Palifermin in Patients Receiving Hematopoietic Cell Transplantation for Hematologic Malignancies. (Saber W, Steinert P, Zhang MJ, Chen M, Pope A, Keating A, Wingard JR, Ballen K, Stiff P, Perales MA, Forman S, Champlin R, Langston A, Rudebeck M, Horowitz M) Transplant Cell Ther 2021 Oct;27(10):837.e1-837.e10 PMID: 34224914 PMCID: PMC8606163 SCOPUS ID: 2-s2.0-85111495021 07/06/2021    
  • Hematopoietic Cell Transplantation Outcomes among Medicaid and Privately Insured Patients with Sickle Cell Disease. (Mupfudze TG, Meyer C, Preussler JM, Mau LW, Bolon YT, Steinert P, Arnold SD, Saber W, Krishnamurti L) Transplant Cell Ther 2021 Aug;27(8):685.e1-685.e8 PMID: 33895405 PMCID: PMC8680220 SCOPUS ID: 2-s2.0-85107426174 04/26/2021       3 Citations
  • Veno-occlusive disease risk in pediatric patients with acute myeloid leukemia treated with gemtuzumab ozogamicin before allogeneic hematopoietic cell transplantation. (Duncan C, St Martin A, Pérez WS, Steinert P, Zhang MJ, Chirnomas D, Hoang CJ, Loberiza FR Jr, Saber W) Pediatr Blood Cancer 2021 Aug;68(8):e29067 PMID: 33871892 PMCID: PMC8324076 SCOPUS ID: 2-s2.0-85104540510 04/20/2021       2 Citations
  • Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma. (Pasquini MC, Hu ZH, Curran K, Laetsch T, Locke F, Rouce R, Pulsipher MA, Phillips CL, Keating A, Frigault MJ, Salzberg D, Jaglowski S, Sasine JP, Rosenthal J, Ghosh M, Landsburg D, Margossian S, Martin PL, Kamdar MK, Hematti P, Nikiforow S, Turtle C, Perales MA, Steinert P, Horowitz MM, Moskop A, Pacaud L, Yi L, Chawla R, Bleickardt E, Grupp S) Blood Adv 2020 Nov 10;4(21):5414-5424 PMID: 33147337 PMCID: PMC7656920 SCOPUS ID: 2-s2.0-85096931359 11/05/2020       250 Citations
  • Current Use of and Trends in Hematopoietic Cell Transplantation in the United States. (D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM) Biol Blood Marrow Transplant 2020 Aug;26(8):e177-e182 PMID: 32438042 PMCID: PMC7404814 SCOPUS ID: 2-s2.0-85085969206 05/22/2020       307 Citations
  • Healthcare Costs of Treating Privately Insured Patients with Acute Myeloid Leukemia in the United States from 2004 to 2014: A Generalized Additive Modeling Approach. (Mau LW, Preussler JM, Burns LJ, Leppke S, Majhail NS, Meyer CL, Mupfudze T, Saber W, Steinert P, Vanness DJ) Pharmacoeconomics 2020 May;38(5):515-526 PMID: 32128725 PMCID: PMC7194165 SCOPUS ID: 2-s2.0-85081593666 03/05/2020       3 Citations
  • Prior Gemtuzumab Ozogamicin Exposure in Adults with Acute Myeloid Leukemia Does Not Increase Hepatic Veno-Occlusive Disease Risk after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis. (Ho VT, Martin AS, Pérez WS, Steinert P, Zhang MJ, Chirnomas D, Hoang CJ, Loberiza FR Jr, Saber W) Biol Blood Marrow Transplant 2020 May;26(5):884-892 PMID: 31891815 PMCID: PMC7439134 SCOPUS ID: 2-s2.0-85078874148 01/01/2020       17 Citations
  • Reimbursement, Utilization, and 1-Year Survival Post-Allogeneic Transplantation for Medicare Beneficiaries With Acute Myeloid Leukemia. (Mau LW, Meyer C, Burns LJ, Saber W, Steinert P, Vanness DJ, Preussler JM, Silver A, Leppke S, Murphy EA, Denzen E) JNCI Cancer Spectr 2019 Dec;3(4):pkz048 PMID: 31750417 PMCID: PMC6845850 SCOPUS ID: 2-s2.0-85084784532 11/22/2019       6 Citations
  • Hematopoietic cell transplant for acute myeloid leukemia and myelodysplastic syndrome: conditioning regimen intensity. (Eapen M, Brazauskas R, Hemmer M, Perez WS, Steinert P, Horowitz MM, Deeg HJ) Blood Adv 2018 Aug 28;2(16):2095-2103 PMID: 30135184 PMCID: PMC6113615 SCOPUS ID: 2-s2.0-85056694237 08/24/2018       58 Citations
  • The Impact of Palifermin Use on Hematopoietic Cell Transplant Outcomes in Children. (Saber W, Zhang MJ, Steinert P, Chen M, Horowitz MM) Biol Blood Marrow Transplant 2016 Aug;22(8):1460-1466 PMID: 27090960 PMCID: PMC4949099 SCOPUS ID: 2-s2.0-84973879084 04/20/2016       6 Citations
    • Last update: 03/22/2024